Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

CrystalsFirst GmbH

CrystalsFirst’s unique technology platform enables customers and collaboration partners rapid access to high-fidelity chemical matter across different drug targets and binding modalities. The company offers its high-performance screening, protein, and structural biology platform to pharmaceutical and biotechnology companies for small molecule drug discovery. Within the broad fields of structure-based drug discovery and fragment-based lead generation, the application of CrystalsFirst’s proprietary technology SmartSoak® provides rapid structural insights into numerous target interaction modes with atomic resolution. The company’s fast access to the highest resolution structural data and molecular design strategies support medicinal chemistry in the development of candidate molecules in a time- and cost-efficient way. *


Period Start 2018-03-01 established (s-off)
Product Industry protein crystallisation technology
  Street 6 Marbacher Weg
  City 35037 Marburg
    Address record changed: 2023-04-18
Basic data Employees n. a.
    * Document for »About Section«: CrystalsFirst GmbH. (2/23/23). "Press Release: CrystalsFirst Establishes Partnership with Akttyva Therapeutics to Support AI-powered Drug Discovery Programs". Hamburg.
Record changed: 2023-12-30


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for CrystalsFirst GmbH

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top